BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
BLCO upcoming catalysts
Bausch & Lomb Incorporated: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 3 readout(s) and 0 FDA event(s). Subscribe to BLCO (.ics).
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|
| No upcoming PDUFA date or AdCom found. |
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2027-02 est. | P2 | Bausch & Lomb Incorporated BLCO | NCT07778888 BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial | Dry Eye Disease | recruiting | 20 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|
| No FDA decision events in this window. |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2026-10-04 | P2 | Bausch & Lomb Incorporated BLCO | NCT07412496 A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy | Pain, Postoperative | completed | 130 |
| 2026-05-28 | P2 | Bausch & Lomb Incorporated BLCO | NCT07128628 A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease | Dry Eye Disease | completed | 443 |
| 2026-05-18 | P2 | Bausch & Lomb Incorporated BLCO | NCT07168902 Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension | Glaucoma | completed | 252 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.